Sanofi (LON:0O59)

Market Cap	107.91B
Revenue (ttm)	36.62B
Net Income (ttm)	4.60B
Shares Out	n/a
EPS (ttm)	3.67
PE Ratio	23.47
Forward PE	n/a
Dividend	3.23 (3.11%)
Ex-Dividend Date	May 13, 2024

Volume	397,958
Average Volume	476,102
Open	102.60
Previous Close	103.58
Day's Range	102.42 - 104.12
52-Week Range	70.18 - 87.94
Beta	0.46
RSI	61.10
Earnings Date	Jan 30, 2025

About Sanofi

Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. The company provides immunology and inflammation, rare diseases, neurology, oncology, and other medicines and vaccines. It also offers poliomyelitis, pertussis, and haemophilus influenzae type b (Hib) pediatric vaccines; respiratory syncytial virus protection and hexavalent combination vaccines protecting against diphtheria, tetanus, pertussis, polio, Hib, and hepatitis B; inf...

• Industry: Pharmaceutical Preparations
• Founded: 1994
• Employees: 82,878
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0O59

Financial Performance

In 2024, Sanofi's revenue was 44.29 billion, an increase of 7.73% compared to the previous year's 41.11 billion. Earnings were 5.56 billion, an increase of 2.96%.

Financial numbers in EUR